Research Article
A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection
Table 2
Overview of immunization regimen.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Complete Freund’s adjuvant was used for the priming vaccine followed by incomplete Freund’s adjuvant for boosters. Challenge with LPAI subtype H5N2 was performed at 8 weeks of age using oculonasal route. |